Invention Grant
![Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile](/docs/US/2023-01-10/US11548895B2/abs.jpg.600x600.jpg)
- Patent Title: Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile
-
Application No.: US16855471Application Date: 2020-04-22
-
Publication No.: US11548895B2Publication Date: 2023-01-10
- Inventor: Jingdan Hu , Timothy Andrew Woods
- Applicant: Elanco US Inc.
- Applicant Address: US IN Greenfield
- Assignee: Elanco US Inc.
- Current Assignee: Elanco US Inc.
- Current Assignee Address: US IN Greenfield
- Agency: McBee Moore & Vanik IP, LLC
- Main IPC: C07D487/04
- IPC: C07D487/04
![Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile](/abs-image/US/2023/01/10/US11548895B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure provides crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile, pharmaceutical compositions comprising the crystalline forms, methods of using the crystalline forms, and processes for making the crystalline forms.
Public/Granted literature
- US20200339585A1 JAK INHIBITORS Public/Granted day:2020-10-29
Information query
